Prespecified subgroup analyses showed that primary surgery conferred greater benefits for patients with stage III disease and ...

A new treatment nearly halves the risk of disease progression or death from a less common form of breast cancer that hasn't ...

Adding immunotherapy to chemotherapy after surgery for stage 3 colon cancer may help decrease recurrence and death rate by 50 ...

The world’s largest meeting on cancer research has brought promising updates on treatment and prevention for colorectal ...

A phase 2 trial shows promising results for pembrolizumab combined with cisplatin and radiation in treating unresectable ...

Abstracts published ahead of the 2025 American Society of Clinical Oncology Annual Meeting found persistent ovarian cancer survival disparities among racial and ethnic subgroups, particularly ...

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

Five early-career Fred Hutch/UW researchers received prestigious Young Investigator Awards from Conquer Cancer, the ASCO Foundation during this year's annual meeting of the American Society of ...

Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without ...

New data support the role of structured exercise and low inflammatory diets to improve survival and quality of life following ...

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...